Are Wall Street Analysts Predicting Baxter International Stock Will Climb or Sink?

With a market cap of $10.1 billion, Baxter International Inc. (BAX) is a global healthcare company that provides a broad portfolio of medical products, technologies, and pharmaceuticals used across hospitals, clinics, and home care settings. It operates worldwide through multiple segments, delivering solutions ranging from IV therapies and injectable drugs to advanced surgical and patient monitoring systems.

Shares of the Deerfield, Illinois-based company have lagged behind the broader market over the past 52 weeks. BAX stock has decreased 40.2% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.3%. However, the stock has risen 3.5% on a YTD basis, outpacing SPX's 1.4% return.